Le T, Truong N, Holterman A
Liver Res. 2025; 7(4):304-320.
PMID: 39958781
PMC: 11792069.
DOI: 10.1016/j.livres.2023.12.001.
Su Q, Sun H, Mei L, Yan Y, Ji H, Chang L
Cell Biosci. 2024; 14(1):133.
PMID: 39487553
PMC: 11529329.
DOI: 10.1186/s13578-024-01316-3.
Zhu Z, Hu S, Zhong X, Zhang Y, Wu X, Lin J
Discov Oncol. 2024; 15(1):572.
PMID: 39424684
PMC: 11489415.
DOI: 10.1007/s12672-024-01454-7.
Helal I, Kamal M, Abd El-Aziz M, El Tayebi H
Expert Rev Mol Med. 2024; 26:e18.
PMID: 39320855
PMC: 11440614.
DOI: 10.1017/erm.2024.9.
Zeng Z, Jia C, Li L, Jia D, Tang R, Li Y
Sci Rep. 2024; 14(1):21086.
PMID: 39256453
PMC: 11387400.
DOI: 10.1038/s41598-024-71629-3.
The Effects of Hypoxia on the Immune-Metabolic Interplay in Liver Cancer.
He Y, Xu H, Liu Y, Kempa S, Vechiatto C, Schmidt R
Biomolecules. 2024; 14(8).
PMID: 39199411
PMC: 11352590.
DOI: 10.3390/biom14081024.
Single-cell analysis revealed that MTIF2 could promote hepatocellular carcinoma progression through modulating the ROS pathway.
Wang Y, Zhang J, Yang Y, Chen J, Tan F, Zheng J
Heliyon. 2024; 10(14):e34438.
PMID: 39082024
PMC: 11284438.
DOI: 10.1016/j.heliyon.2024.e34438.
Engineering principles for rationally design therapeutic strategies against hepatocellular carcinoma.
Hernandez-Magana A, Bensussen A, Martinez-Garcia J, Alvarez-Buylla E
Front Mol Biosci. 2024; 11:1404319.
PMID: 38939509
PMC: 11208463.
DOI: 10.3389/fmolb.2024.1404319.
Tumor-Extrinsic Axl Expression Shapes an Inflammatory Microenvironment Independent of Tumor Cell Promoting Axl Signaling in Hepatocellular Carcinoma.
Breitenecker K, Heiden D, Demmer T, Weber G, Primorac A, Hedrich V
Int J Mol Sci. 2024; 25(8).
PMID: 38673795
PMC: 11050718.
DOI: 10.3390/ijms25084202.
The Role of microRNAs in Hepatocellular Cancer: A Narrative Review Focused on Tumor Microenvironment and Drug Resistance.
Tavakoli Pirzaman A, Alishah A, Babajani B, Ebrahimi P, Sheikhi S, Moosaei F
Technol Cancer Res Treat. 2024; 23:15330338241239188.
PMID: 38634139
PMC: 11025440.
DOI: 10.1177/15330338241239188.
The role of CSTF2 in cancer: from technology to clinical application.
Ding J, Su Y, Liu Y, Xu Y, Yang D, Wang X
Cell Cycle. 2024; 22(23-24):2622-2636.
PMID: 38166492
PMC: 10936678.
DOI: 10.1080/15384101.2023.2299624.
Function of microRNA‑124 in the pathogenesis of cancer (Review).
Liu Y, Yang Y, Wang X, Yin S, Liang B, Zhang Y
Int J Oncol. 2023; 64(1).
PMID: 38038165
PMC: 10705041.
DOI: 10.3892/ijo.2023.5594.
Prognostic significance of programmed cell death-ligand 1 expression on immune cells and epithelial-mesenchymal transition expression in patients with hepatocellular carcinoma.
Jung H, Ahn H, Oh M, Yun J, Lee H, Bae S
Ann Surg Treat Res. 2023; 105(5):297-309.
PMID: 38023431
PMC: 10648616.
DOI: 10.4174/astr.2023.105.5.297.
The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma.
Ghionescu A, Sorop A, Dima S
Front Pharmacol. 2023; 14:1270425.
PMID: 37767397
PMC: 10520284.
DOI: 10.3389/fphar.2023.1270425.
Regulation of Hepatocellular Carcinoma Epithelial-Mesenchymal Transition Mechanism and Targeted Therapeutic Approaches.
Yuregir Y, Kacaroglu D, Yaylaci S
Adv Exp Med Biol. 2023; 1450:93-102.
PMID: 37452258
DOI: 10.1007/5584_2023_781.
Lipid-Independent Regulation of PLIN5 via IL-6 through the JAK/STAT3 Axis in Hep3B Cells.
Krizanac M, Mass Sanchez P, Schroder S, Weiskirchen R, Asimakopoulos A
Int J Mol Sci. 2023; 24(8).
PMID: 37108378
PMC: 10138877.
DOI: 10.3390/ijms24087219.
ASAP2 interrupts c-MET-CIN85 interaction to sustain HGF/c-MET-induced malignant potentials in hepatocellular carcinoma.
Ma X, Nie Y, Xie S, Zheng H, Tong Y, Wang Y
Exp Hematol Oncol. 2023; 12(1):38.
PMID: 37061723
PMC: 10105420.
DOI: 10.1186/s40164-023-00393-3.
Biological function analysis of ARHGAP39 as an independent prognostic biomarker in hepatocellular carcinoma.
Ding Y, Gong Y, Zeng H, Zhou X, Yu Z, Pan J
Aging (Albany NY). 2023; 15(7):2631-2666.
PMID: 37059586
PMC: 10120899.
DOI: 10.18632/aging.204635.
Ameliorative Effect of on High Glucose-Related Stress in Human Hepatoma HepG2 Cells.
Vasarri M, Barletta E, Stio M, Bergonzi M, Galli A, DeglInnocenti D
Int J Mol Sci. 2023; 24(6).
PMID: 36982278
PMC: 10048879.
DOI: 10.3390/ijms24065203.
TNFR2 is a potent prognostic biomarker for post-transplant lung metastasis in patients with hepatocellular carcinoma.
Li H, Lin Z, Zhuo J, Yang M, Shen W, Hu Z
Chin J Cancer Res. 2023; 35(1):66-80.
PMID: 36910852
PMC: 9992998.
DOI: 10.21147/j.issn.1000-9604.2023.01.07.